Lunai Bioworks Heads Into Key Week After Reverse Split, Ongoing Court Battle
Lunai Bioworks Inc. starts the holiday-shortened week trading above Nasdaq’s $1 minimum after a reverse split. But the stock faces deadline pressure to keep its listing. The biotech is also dealing with thin trading and a fresh lawsuit over alleged short selling. The shares ended Friday at $2.26, dropping 2.62%. Volume came in near 206,000 shares based on historical market data. The stock moved between $2.11 and $2.40 in the session.